Orbimed Advisors LLC Aptinyx Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $3.62 $478,970 - $763,820	-211,000 Reduced 28.15%	538,500 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$2.11 - $3.0 $1.26 Million - $1.79 Million	596,215 Added 388.96%	749,500 $2 Million
Q3 2021 Nov 15, 2021	BUY	$2.21 - $2.89 $338,759 - $442,993	153,285 New	153,285 $359,000
Q2 2020 Aug 14, 2020	SELL	$1.99 - $4.4 $2.31 Million - $5.11 Million	-1,162,108 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.81 - $5.03 $1.84 Million - $5.13 Million	1,019,108 Added 712.66%	1,162,108 $2.51 Million
Q4 2019 Feb 14, 2020	BUY	$2.84 - $4.25 $406,120 - $607,750	143,000 New	143,000 $489,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.